Skip to Main content Skip to Navigation
Journal articles

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma Real World Evidence from the French Early Access Program

Roch Houot 1, 2 Guillaume Manson 3 Jean-Baptiste Mear 3 Charles Herbaux 4 Jean Marc Schiano de Collela 5 René-Olivier Casasnovas 6 Aspasia Stamatoullas 7 Benedicte Deau-Fisher 8 Anna Schmitt 9 Georges Garnier 10 Lysiane Molina 11 Krimo Bouabdallah 12 Marie-Pierre Moles 13 Hervé Ghesquieres 14 Adrian Tempescul 15 Remy Dulery 16 Emmanuelle Nicolas-Virelizier 17 Alain Jacques Delmer 18 Cécile Borel 19 Adrien Chauchet 20 Laurent Dercle 21 Pauline Brice 22 
Document type :
Journal articles
Complete list of metadata

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02076926
Contributor : Xavier Chard-Hutchinson Connect in order to contact the contributor
Submitted on : Friday, March 22, 2019 - 2:32:46 PM
Last modification on : Thursday, August 4, 2022 - 5:25:55 PM

Links full text

Identifiers

Citation

Roch Houot, Guillaume Manson, Jean-Baptiste Mear, Charles Herbaux, Jean Marc Schiano de Collela, et al.. Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma Real World Evidence from the French Early Access Program. Blood, American Society of Hematology, 2018, 132 (1), pp.1638. ⟨10.1182/blood-2018-99-110960⟩. ⟨hal-02076926⟩

Share

Metrics

Record views

51